Mega Genomics Limited (HKG:6667)

Mega Genomics Statistics

Total Valuation

Mega Genomics has a market cap or net worth of HKD 1.63 billion. The enterprise value is 1.18 billion.

Market Cap	1.63B
Enterprise Value	1.18B

Important Dates

The last earnings date was Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

Mega Genomics has 224.30 million shares outstanding. The number of shares has decreased by -4.81% in one year.

Current Share Class	224.30M
Shares Outstanding	224.30M
Shares Change (YoY)	-4.81%
Shares Change (QoQ)	-6.83%
Owned by Insiders (%)	22.89%
Owned by Institutions (%)	0.01%
Float	119.36M

Valuation Ratios

The trailing PE ratio is 47.80.

PE Ratio	47.80
Forward PE	n/a
PS Ratio	5.94
PB Ratio	2.40
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	39.27
EV / Sales	4.29
EV / EBITDA	29.73
EV / EBIT	39.94
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.64, with a Debt / Equity ratio of 0.05.

Current Ratio	3.64
Quick Ratio	3.30
Debt / Equity	0.05
Debt / EBITDA	0.82
Debt / FCF	n/a
Interest Coverage	19.45

Financial Efficiency

Return on equity (ROE) is 4.41% and return on invested capital (ROIC) is 10.69%.

Return on Equity (ROE)	4.41%
Return on Assets (ROA)	2.11%
Return on Invested Capital (ROIC)	10.69%
Return on Capital Employed (ROCE)	4.20%
Weighted Average Cost of Capital (WACC)	8.62%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	203
Asset Turnover	0.31
Inventory Turnover	5.89

Taxes

In the past 12 months, Mega Genomics has paid 6.46 million in taxes.

Income Tax	6.46M
Effective Tax Rate	17.69%

Stock Price Statistics

The stock price has increased by +1.11% in the last 52 weeks. The beta is 0.81, so Mega Genomics's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+1.11%
50-Day Moving Average	7.18
200-Day Moving Average	8.09
Relative Strength Index (RSI)	51.15
Average Volume (20 Days)	3,670

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mega Genomics had revenue of HKD 275.03 million and earned 30.07 million in profits. Earnings per share was 0.15.

Revenue	275.03M
Gross Profit	130.60M
Operating Income	29.57M
Pretax Income	36.53M
Net Income	30.07M
EBITDA	39.72M
EBIT	29.57M
Earnings Per Share (EPS)	0.15

Balance Sheet

The company has 484.85 million in cash and 32.68 million in debt, with a net cash position of 452.17 million or 2.02 per share.

Cash & Cash Equivalents	484.85M
Total Debt	32.68M
Net Cash	452.17M
Net Cash Per Share	2.02
Equity (Book Value)	679.86M
Book Value Per Share	3.57
Working Capital	586.92M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	10.48M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 47.49%, with operating and profit margins of 10.75% and 10.93%.

Gross Margin	47.49%
Operating Margin	10.75%
Pretax Margin	13.28%
Profit Margin	10.93%
EBITDA Margin	14.44%
EBIT Margin	10.75%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 2.37%.

Dividend Per Share	0.17
Dividend Yield	2.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.81%
Shareholder Yield	7.17%
Earnings Yield	1.84%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4